Plant composition, traditional Chinese medicine composition and use thereof

ChangeBridge: Patent Grants - Pharma (A61K)

Published April 7th, 2026

Detected April 7th, 2026

Summary

The USPTO granted Patent US12594316B2 to the National Research Institute of Chinese Medicine for a traditional Chinese medicine composition comprising eleven herbal ingredients including Aconitum carmichaelii, Polygonatum odoratum, and Scutellaria baicalensis. The patented composition is indicated for treating pulmonary embolism or pulmonary fibrosis. The patent contains 10 claims and was filed on October 19, 2022.

View original document View source feed page

What changed

USPTO issued Patent US12594316B2 granting exclusive rights to the National Research Institute of Chinese Medicine for a plant-based traditional Chinese medicine composition. The composition includes ten herbal ingredients combined to form a therapeutic preparation. The patent specifically claims use of the composition for treating pulmonary embolism and pulmonary fibrosis conditions.

This patent grant confers intellectual property protection on the assignee, potentially restricting competitors from manufacturing, using, or selling similar traditional Chinese medicine compositions for pulmonary applications without license. Pharmaceutical manufacturers or traditional medicine developers working with similar herbal combinations for pulmonary treatments should assess patent landscape and freedom-to-operate implications.

What to do next

Monitor for updates

Source document (simplified)

← USPTO Patent Grants

Plant composition, traditional Chinese medicine composition and use thereof

Grant US12594316B2 Kind: B2 Apr 07, 2026

Assignee

National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Inventors

Yi-Chang Su, Wen-Hui Chiou, Yuh-Chiang Shen, Wen-Chi Wei, Keng-Chang Tsai, Chia-Ching Liao, Yu-Hwei Tseng, Chun-Tang Chiou, Yu-Chi Lin, Li-Hsiang Wang

Abstract

The present invention relates to a plant composition, a traditional Chinese medicine composition and use thereof. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata) and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition. In addition, the traditional Chinese medicine composition can be used to treat pulmonary embolism or pulmonary fibrosis.